Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   acquired hemophilia
  

Disease ID 1159
Disease acquired hemophilia
Definition
Acquired hemophilia is a rare autoimmune disorder characterized by bleeding that occurs in patients with a personal and family history negative for hemorrhages. Autoimmune disorders occur when the body's immune system mistakenly attacks healthy cells or tissue. In acquired hemophilia, the body produces antibodies (known as inhibitors) that attack clotting factors, most often factor VIII. Clotting factors are specialized proteins required for the blood to clot normally. Consequently, affected individuals develop complications associated with abnormal, uncontrolled bleeding into the muscles, skin and soft tissue and during surgery or following trauma. Specific symptoms can include nosebleeds (epistaxis), bruising throughout the body, solid swellings of congealed blood (hematomas), blood in the urine (hematuria) and gastrointestinal or urogenital bleeding. Acquired hemophilia can potentially cause severe, life-threatening bleeding complications in severe cases. In approximately 50% of cases, there is an identifiable underlying clinical condition; in the other 50% no cause is known (idiopathic).Acquired hemophilia is different from congenital hemophilia, a group of rare genetic disorders caused by congenital deficiency of certain clotting factors. The main form of hemophilia is hemophilia A (classic hemophilia), which is an X-linked disorder that fully affects males only. It is caused by deficiency or inactivation of factor VIII, the same clotting factor that is affected in most cases of acquired hemophilia. Although both disorders involve deficiency of the same clotting factor, the bleeding pattern is quite different. The reason the bleeding patterns differ between these disorders is not fully understood. - NORD
Reference: NORD
Synonym
acquired haemophilia
Orphanet
ICD10
UMLS
C1096116
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:32)
C0030805  |  bullous pemphigoid  |  3
C0023418  |  leukaemia  |  2
C0030805  |  pemphigoid  |  2
C0019196  |  hepatitis c  |  2
C0019158  |  hepatitis  |  2
C0035078  |  renal failure  |  1
C0035435  |  rheumatic disease  |  1
C0019069  |  haemophilia  |  1
C0034150  |  purpura  |  1
C0001815  |  myelofibrosis  |  1
C0019829  |  hodgkin lymphoma  |  1
C0026986  |  myelodysplastic syndrome  |  1
C0600139  |  prostate carcinoma  |  1
C0024299  |  lymphoma  |  1
C0376358  |  prostate cancer  |  1
C0024305  |  non-hodgkin lymphoma  |  1
C0024141  |  systemic lupus erythematosus  |  1
C0022660  |  acute renal failure  |  1
C0009492  |  compartment syndrome  |  1
C0027051  |  myocardial infarct  |  1
C0035435  |  rheumatic diseases  |  1
C0409974  |  lupus erythematosus  |  1
C0032533  |  polymyalgia rheumatica  |  1
C0026764  |  multiple myeloma  |  1
C0003864  |  arthritis  |  1
C0001815  |  primary myelofibrosis  |  1
C0024115  |  lung disease  |  1
C0036421  |  systemic sclerosis  |  1
C0040028  |  essential thrombocythemia  |  1
C0027051  |  myocardial infarction  |  1
C0026896  |  myasthenia gravis  |  1
C0003873  |  rheumatoid arthritis  |  1
Curated Gene(Waiting for update.)
Inferring Gene(Waiting for update.)
Text Mined Gene(Waiting for update.)
Locus(Waiting for update.)
Disease ID 1159
Disease acquired hemophilia
Integrated Phenotype
HPO | Name(Total Integrated Phenotypes:12)
HP:0001892  |  Abnormal bleeding
HP:0005261  |  Joint hemorrhage
HP:0002239  |  Gastrointestinal hemorrhage
HP:0003645  |  Prolonged partial thromboplastin time
HP:0003125  |  Reduced factor VIII activity
HP:0000790  |  Hematuria
HP:0011891  |  Post-partum hemorrhage
HP:0002170  |  Intracranial hemorrhage
HP:0030057  |  Autoimmune antibody positivity
HP:0012233  |  Intramuscular hematoma
HP:0001903  |  Anemia
HP:0001933  |  Subcutaneous hemorrhage
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:18)
HP:0012115  |  Liver inflammation  |  2
HP:0200123  |  Chronic liver inflammation  |  2
HP:0006775  |  Multiple myeloma  |  1
HP:0030731  |  Carcinoma  |  1
HP:0002725  |  Systemic lupus erythematosus  |  1
HP:0002863  |  Myelodysplastic syndrome  |  1
HP:0012189  |  Hodgkin disease  |  1
HP:0012125  |  Prostate cancer  |  1
HP:0001370  |  Rheumatoid arthritis  |  1
HP:0002665  |  Lymphoma  |  1
HP:0003473  |  Fatigable weakness  |  1
HP:0000979  |  Purpura  |  1
HP:0001369  |  Arthritis  |  1
HP:0001919  |  Acute renal failure  |  1
HP:0002239  |  Gastrointestinal hemorrhage  |  1
HP:0001658  |  Myocardial infarction  |  1
HP:0002584  |  Intestinal hemorrhage  |  1
HP:0012539  |  Non-Hodgkin lymphoma  |  1
Disease ID 1159
Disease acquired hemophilia
Manually Symptom
UMLS  | Name(Total Manually Symptoms:6)
C0085932  |  bullous dermatosis
C0085932  |  bullous dermatoses
C0030809  |  pemphigus vulgaris
C0019080  |  hemorrhage
C0018924  |  hemarthrosis
C0001883  |  airway obstruction
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:1)
C0019080  |  hemorrhage  |  3
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:0)
(Waiting for update.)
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:6)
HP ID HP Name MP ID MP Name Annotation
HP:0003645Prolonged partial thromboplastin timeMP:0012359increased partial thromboplastin timeincreased amount of time it takes blood to clot after the addition of phospholipid, calcium, and an activator, e.g., silica, kaolin; measure of the quality of the intrinsic and common coagulation pathways
HP:0001933Subcutaneous hemorrhageMP:0011437glomerulus hemorrhagebleeding in the renal glomerulus
HP:0002239Gastrointestinal hemorrhageMP:0012305umbilical cord hemorrhagebleeding into or from the umbilical cord
HP:0002170Intracranial hemorrhageMP:0006203eye hemorrhagebleeding into the eye
HP:0005261Joint hemorrhageMP:0012305umbilical cord hemorrhagebleeding into or from the umbilical cord
HP:0001892Abnormal bleedingMP:0005606increased bleeding timegreater than the normal duration of blood flow after skin puncture; indicative of platelet and capillary function
Mapped by homologous gene(Total Items:10)
HP ID HP Name MP ID MP Name Annotation
HP:0000790HematuriaMP:0020316decreased vascular endothelial cell proliferationdecrease in the expansion rate of any vascular endothelial cell population by cell division
HP:0005261Joint hemorrhageMP:0020215impaired blood coagulationimpaired ability of the blood to clot
HP:0001933Subcutaneous hemorrhageMP:0020329decreased capillary densityreduction in the number of capillaries in a given cross-sectional area of a tissue
HP:0012233Intramuscular hematomaMP:0011110preweaning lethality, incomplete penetrancethe appearance of lower than Mendelian ratios of organisms of a given genotype due to death of some, but not all of the organisms between fertilization and weaning age (Mus: approximately 3-4 weeks of age)
HP:0003125Reduced factor VIII activityMP:0020215impaired blood coagulationimpaired ability of the blood to clot
HP:0001892Abnormal bleedingMP:0020138delayed bone mineralizationlate onset of the process by which minerals are deposited into bone
HP:0002170Intracranial hemorrhageMP:0020137decreased bone mineralizationdecrease in the rate at which minerals are deposited into bone
HP:0002239Gastrointestinal hemorrhageMP:0020215impaired blood coagulationimpaired ability of the blood to clot
HP:0003645Prolonged partial thromboplastin timeMP:0020215impaired blood coagulationimpaired ability of the blood to clot
HP:0001903AnemiaMP:0020316decreased vascular endothelial cell proliferationdecrease in the expansion rate of any vascular endothelial cell population by cell division
Disease ID 1159
Disease acquired hemophilia
Case(Waiting for update.)